Anthropic IPO Becomes a Test of the AI Capital Cycle
Anthropic's proposed Nasdaq listing gives public investors a new way to assess AI growth, infrastructure commitments and governance risk.
Tag: EXCLUSIVE
SoftBank Plans US$50 Billion Malaysia Technology Investment
SoftBank's reported US$50 billion Malaysia plan could deepen the country's AI and data-centre ecosystem, subject to project-level commitments and approvals.
DeepSeek and MiniMax Gain Clearance for Overseas AI Use
DeepSeek and MiniMax have completed Chinese registration procedures for open-source releases and overseas licensing of their artificial-intelligence models.
Malaysia Wants a Bigger Role in Global Entertainment. The Opportunity Is Behind the Camera
A potential collaboration with Netflix highlights an opportunity for Malaysia to move beyond filming locations and capture more value from the international entertainment industry.
Samsung and SK Hynix Plan China Memory Upgrades for AI Demand
Samsung Electronics and SK Hynix are preparing China memory-plant upgrades as AI demand rises and US equipment licences shape execution.
Nvidia and Germany Put Physical AI at the Centre of Industrial Renewal
Nvidia and Germany are pairing industrial expertise with physical AI, creating opportunities in automation while leaving productivity returns to be proven.
United States Orders DeepSeek Removed from Civilian Federal IT Systems
The United States has ordered DeepSeek-related products removed from civilian federal IT systems while excluding them from future agency procurement.
China Holds Lending Rates for 17th Month as Policy Focus Shifts to Transmission
China left its one-year and five-year loan prime rates unchanged for a 17th month as investors turned to credit transmission and demand.
Malaysia Exports Surge 54.5% as US and China Demand Strengthens
Malaysia's exports recorded their fastest growth since April 2021, led by electrical and electronic products and stronger US and China demand.
China Cancer Trial Reports 84% Disease Control Using Nano-Carbon Iron Injection
Chinese researchers reported an 84.2% disease control rate in a small Phase I trial of CNSI-Fe, an experimental nano-carbon iron cancer treatment.